Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Franklin Covey
FC
$229M
| $4.63M | ﹤0.01% |
120,237
+42,886
| +55% | +$1.98M |
|
3877
PUT
BridgeBio Pharma
BBIO
$15.6B
| $4.62M | ﹤0.01% |
278,800
+264,300
| +1,823% | +$3.08M |
|
3878
NerdWallet
NRDS
$629M
| $4.62M | ﹤0.01% |
285,477
+266,984
| +1,444% | +$4.02M |
|
3879
PUT
iShares MSCI Spain ETF
EWP
$2.22B
| $4.62M | ﹤0.01% |
165,700
+118,100
| +248% | +$3.17M |
|
3880
Biohaven
BHVN
$2.21B
| $4.61M | ﹤0.01% |
337,527
+270,575
| +404% | +$4.31M |
|
3881
CALL
Kinross Gold
KGC
$32.4B
| $4.61M | ﹤0.01% |
978,800
+228,600
| +30% | +$969K |
|
3882
CALL
iShares Core S&P Total US Stock Market ETF
ITOT
$98.3B
| $4.61M | ﹤0.01% |
50,900
-69,600
| -58% | -$6.18M |
|
3883
iShares Dow Jones US ETF
IYY
$3.09B
| $4.61M | ﹤0.01% |
+46,026
| New | +$4.5M |
|
3884
Primoris Services
PRIM
$4.48B
| $4.6M | ﹤0.01% |
186,677
-276,199
| -60% | -$6.98M |
|
3885
Codexis
CDXS
$171M
| $4.6M | ﹤0.01% |
1,111,849
+152,149
| +16% | +$798K |
|
3886
CALL
Jones Lang LaSalle
JLL
$17.3B
| $4.6M | ﹤0.01% |
31,600
+5,600
| +22% | +$933K |
|
|
RVNC
3887
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.6M | ﹤0.01% |
142,700
+7,200
| +5% | +$224K |
|
3888
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$534M
| $4.59M | ﹤0.01% |
108,900
+17,500
| +19% | +$665K |
|
3889
Crinetics Pharmaceuticals
CRNX
$8.99B
| $4.59M | ﹤0.01% |
285,595
+248,239
| +665% | +$4.59M |
|
3890
Fabrinet
FN
$20.4B
| $4.59M | ﹤0.01% |
38,612
-16,355
| -30% | -$2.03M |
|
|
ADAM
3891
Adamas Trust
ADAM
$910M
| $4.58M | ﹤0.01% |
460,300
+141,644
| +44% | +$1.53M |
|
3892
CALL
Chemours
CC
$2.39B
| $4.58M | ﹤0.01% |
153,000
-85,700
| -36% | -$2.82M |
|
3893
JPMorgan BetaBuilders Japan ETF
BBJP
$19.1B
| $4.58M | ﹤0.01% |
94,622
-13,673
| -13% | -$642K |
|
3894
Samsara
IOT
$23.2B
| $4.56M | ﹤0.01% |
231,388
-262,887
| -53% | -$4.17M |
|
3895
TaskUs
TASK
$688M
| $4.56M | ﹤0.01% |
315,984
+279,332
| +762% | +$4.86M |
|
3896
Kanzhun
BZ
$6.93B
| $4.56M | ﹤0.01% |
239,471
+101,908
| +74% | +$2.22M |
|
3897
Vanguard FTSE Pacific ETF
VPL
$8.64B
| $4.55M | ﹤0.01% |
+67,134
| New | +$4.51M |
|
3898
PUT
Sprott Uranium Miners ETF
URNM
$2B
| $4.55M | ﹤0.01% |
145,100
-111,900
| -44% | -$3.74M |
|
|
INZY
3899
DELISTED
Inozyme Pharma
INZY
| $4.55M | ﹤0.01% |
+793,823
| New | +$2.1M |
|
3900
PUT
Calumet Specialty Products
CLMT
$4.19B
| $4.55M | ﹤0.01% |
261,600
+137,200
| +110% | +$2.44M |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.